Valuation Alterity Therapeutics OTC Markets

Stocks

Market Closed - OTC Markets Other stock markets 11:50:46 2026-04-01 EDT			5-day change	1st Jan Change
0.0550 ^USD	+450.00%		-.--%	-82.40%

06-09	Alterity Therapeutics Achieves Alignment With U.S. FDA On Pivotal Phase 3 Program For ATH434 In Multiple System Atrophy	CI
06-03	Alterity Therapeutics Limited Announces Change of Registered Office Address	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	43.75	21.56	11.37	14	59.84	91.5	-	-
Change	-	-50.72%	-47.27%	23.14%	327.48%	52.91%	-	-
Enterprise Value (EV) ¹	43.75	21.56	11.37	9.172	38.2	46.31	50.62	54.4
Change	-	-50.72%	-47.27%	-19.31%	316.5%	21.22%	9.3%	7.46%
P/E	-	-	-	-	-	-0.24x	-0.24x	-0.24x
PBR	-	-	-	-	-	-	-	-
PEG	-	-	-	-	-	-	-	-
Capitalization / Revenue	13.3x	6.11x	4.45x	4.81x	11.3x	26.7x	57.2x	28.8x
EV / Revenue	13.3x	6.11x	4.45x	3.15x	7.24x	13.5x	31.6x	17.1x
EV / EBITDA	-	-	-	-0.71x	-4.68x	-2.96x	-2.23x	-2.34x
EV / EBIT	-4.07x	-2.07x	-1.22x	-0.71x	-4.87x	-3.02x	-2.07x	-1.92x
EV / FCF	-	-2.53x	-	-1.07x	-5.11x	-4.43x	-2.33x	-2.54x
FCF Yield	-	-39.6%	-	-93.4%	-19.6%	-22.6%	-43%	-39.3%
Dividend per Share ³	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ³	-	-	-	-	-	-2.5	-2.5	-2.5
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3.292	3.528	2.554	2.909	5.278	3.425	1.6	3.177
EBITDA ¹	-	-	-	-12.95	-8.155	-15.64	-22.74	-23.26
EBIT ¹	-10.75	-10.42	-9.321	-12.97	-7.839	-15.32	-24.43	-28.33
Net income ¹	-11.19	-8.843	-8.966	-12.97	-7.927	-13.44	-22.29	-25.74
Net Debt ¹	-	-	-	-4.826	-21.64	-45.19	-40.88	-37.1
Reference price ³	1.4000	0.6500	0.3500	0.2000	0.5000	0.6000	0.6000	0.6000
Nbr of stocks (in thousands)	41,680	48,137	48,798	104,902	182,547	217,508	-	-
Announcement Date	8/31/21	8/31/22	8/31/23	8/29/24	8/28/25	-	-	-